Literature DB >> 18159416

Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001.

Raymond Sw Tsang1, Susan G Squires, Wendell D Zollinger, Fraser E Ashton.   

Abstract

The relative frequency of serogroups of Neisseria meningitidis associated with meningococcal disease in Canada during the period January 1, 1999 to June 30, 2001 was examined. Of the 552 strains of N meningitidis collected from clinical specimens of normally sterile sites, 191 (34.6%), 276 (50.0%), 61 (11.1%) and 23 (4.2%) were identified by serological and molecular methods as serogroups B, C, Y and W135, respectively. About half (50.8%) of the serogroup Y isolates were isolated in the province of Ontario. The two most common serotypes found were 2c and 14. Most of the serogroup Y strains isolated from patients in Ontario were serotype 2c, while serotype 14 was the most common serotype associated with disease in the province of Quebec. The two most common serosubtypes found among the serogroup Y meningococci were P1.5 and P1.2,5. Laboratory findings, based on antigenic analysis, did not suggest that these serogroup Y strains arise by capsule switching from serogroups B and C strains. This study documented a higher incidence of finding serogroup Y meningococci in clinical specimens from patients in Ontario compared to the rest of Canada, and parallels the increase in serogroup Y meningococcal disease reported in some parts of the United States.

Entities:  

Keywords:  Meningococcal disease; Neisseria meningitidis; Serogroups

Year:  2002        PMID: 18159416      PMCID: PMC2094894          DOI: 10.1155/2002/891673

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  22 in total

1.  Two serologically non-groupable Neisseria meningitidis strains from clinical specimens identified by molecular method as serogroup B meningococci.

Authors:  R S Tsang; D Law; S G Squires
Journal:  Can Commun Dis Rep       Date:  2001-01-01

2.  Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998.

Authors:  S G Squires; L Pelletier; M Mungai; R Tsang; F Collins; J Stoltz
Journal:  Can Commun Dis Rep       Date:  2000-11-01

3.  The panmictic nature of Neisseria meningitidis serogroup B during a period of endemic disease in Canada.

Authors:  F E Ashton; D A Caugant
Journal:  Can J Microbiol       Date:  2001-04       Impact factor: 2.419

4.  Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China.

Authors:  J F Wang; D A Caugant; X Li; X Hu; J T Poolman; B A Crowe; M Achtman
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

5.  New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4.

Authors:  D R Martin; S J Walker; M G Baker; D R Lennon
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

6.  Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986.

Authors:  D A Caugant; P Bol; E A Høiby; H C Zanen; L O Frøholm
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

7.  Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.

Authors:  M L Tondella; T Popovic; N E Rosenstein; D B Lake; G M Carlone; L W Mayer; B A Perkins
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

8.  Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world.

Authors:  J Jelfs; R Munro; F E Ashto; D A Caugant
Journal:  Epidemiol Infect       Date:  2000-10       Impact factor: 2.451

9.  Serogroup Y meningococcal disease in Chicago, 1991-1997.

Authors:  J A Racoosin; C G Whitney; C S Conover; P S Diaz
Journal:  JAMA       Date:  1998 Dec 23-30       Impact factor: 56.272

10.  Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada.

Authors:  F E Ashton; J A Ryan; A Borczyk; D A Caugant; L Mancino; D Huang
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

View more
  11 in total

1.  DNA Sequence analysis of the PorB protein of nonserotypeable serogroup C ET-15 meningococci suggests a potential mutational hot spot on their serotype antigens.

Authors:  Dennis K S Law; Averil M Henderson; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Invasive meningococcal disease caused by Neisseria meningitidis strains expressing both serogroup Y and W-135 antigenic specificities.

Authors:  Karen M Rudolph; Carolynn DeByle; Alisa Reasonover; Tammy Zulz; Dennis K S Law; Jianwei Zhou; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

3.  Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.

Authors:  Jianwei Zhou; Frances Jamieson; Sharon Dolman; Linda Mn Hoang; Prasad Rawte; Raymond Sw Tsang
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

4.  Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada.

Authors:  Raymond S W Tsang; Averil M Henderson; Marissa L Cameron; Shaun D Tyler; Shari Tyson; Dennis K S Law; Jan Stoltz; Wendell D Zollinger
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948

5.  Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006.

Authors:  Elizabeth M Brown; David N Fisman; Steven J Drews; Sharon Dolman; Prasad Rawte; Shirley Brown; Frances Jamieson
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

6.  Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay.

Authors:  Raymond S W Tsang; Wendell D Zollinger
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

7.  Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada.

Authors:  Raymond S W Tsang; Chao Ming Tsai; Peixuan Zhu; Louise Ringuette; Manon Lorange; Dennis K S Law
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Potential capsule switching from serogroup Y to B: The characterization of three such Neisseria meningitidis isolates causing invasive meningococcal disease in Canada.

Authors:  Raymond Sw Tsang; Dennis Ks Law; Shaun D Tyler; Gwen S Stephens; Mark Bigham; Wendell D Zollinger
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

Review 9.  The changing epidemiology of meningococcal disease in North America 1945-2010.

Authors:  Carmen Baccarini; Andrew Ternouth; Heather Wieffer; Andrew Vyse
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

10.  Outbreak of serogroup C meningococcal disease caused by a variant of Neisseria meningitidis serotype 2a ET-15 in a community of men who have sex with men.

Authors:  Raymond S W Tsang; Lori Kiefer; Dennis K S Law; Jan Stoltz; Rita Shahin; Shirley Brown; Frances Jamieson
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.